Literature DB >> 24218069

Fas gene variants in childhood acute lymphoblastic leukemia and association with prognosis.

Behnaz Valibeigi1, Zahra Amirghofran, Hossein Golmoghaddam, Reza Hajihosseini, Fatemeh M Kamazani.   

Abstract

Fas molecule is one of the main important molecules involved in apoptotic cell death. Single nucleotide polymorphisms in the promoter of Fas gene at positions -1377G/A and -670 A/G may affect its expression and play an important role in the pathology of leukemia. In the present study the association between these polymorphisms and risk of the development of acute lymphoblastic leukemia (ALL) in children with ALL compared to cancer-free control subjects was examined by polymerase chain reaction- based restriction fragment length polymorphism. The relationship between the polymorphisms and clinical and laboratory features of the patients and response to therapy were determined. No significant differences in genotype and allele frequencies between the patients and the control subjects at positions -670 and -1377 were detected. Evaluation of the prognostic factors revealed an association between the GG genotype at position -670 and liver involvement in ALL patients (p < 0.04). Although patients with -1377 AA genotype showed shorter mean complete remission duration, the result of survival analysis did not reach to be significant. In conclusion, results of this study showed no contribution of Fas genotypes at positions -670 and -1377 to risk of ALL in children. The association of Fas GG genotype at position -670 with liver involvement in the patients may show its important role in prognosis of ALL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218069     DOI: 10.1007/s12253-013-9705-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  35 in total

1.  Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.

Authors:  Weimin Zhang; Chen Li; Jing Wang; Chao He
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

2.  FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.

Authors:  Parinda A Mehta; Robert B Gerbing; Todd A Alonzo; James S Elliott; Tiffany A Zamzow; Michelle Combs; Emily Stover; Julie A Ross; John P Perentesis; Soheil Meschinchi; Beverly J Lange; Stella M Davies
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

3.  FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.

Authors:  Zhizhong Zhang; Hengchuan Xue; Weida Gong; Meilin Wang; Lin Yuan; Suping Han; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2009-01-23       Impact factor: 4.944

4.  CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.

Authors:  C Beltinger; E Kurz; T Böhler; M Schrappe; W D Ludwig; K M Debatin
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  Mutations in the Fas antigen in patients with multiple myeloma.

Authors:  T H Landowski; N Qu; I Buyuksal; J S Painter; W S Dalton
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.

Authors:  X Zhang; X Miao; T Sun; W Tan; S Qu; P Xiong; Y Zhou; D Lin
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

7.  Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.

Authors:  A M Peters; B Kohfink; H Martin; F Griesinger; B Wörmann; M Gahr; J Roesler
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

Review 8.  Defining CD95 as a tumor suppressor gene.

Authors:  M Müschen; U Warskulat; M W Beckmann
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 9.  Cell death mechanisms induced by cytotoxic lymphocytes.

Authors:  L Chávez-Galán; M C Arenas-Del Angel; E Zenteno; R Chávez; R Lascurain
Journal:  Cell Mol Immunol       Date:  2009-02       Impact factor: 11.530

10.  Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Authors:  Kathryn Sibley; Sara Rollinson; James M Allan; Alexandra G Smith; Graham R Law; Philippa L Roddam; Christine F Skibola; Martyn T Smith; Gareth J Morgan
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  9 in total

1.  Association between Fas/FasL polymorphism and susceptibility to leukemia: a meta-analysis.

Authors:  Yiran Chen; Yiho He; Xiaotong Lu; Zhirui Zeng; Chen Tang; Tongyuan Xue; Yuhua Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

3.  Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.

Authors:  Alireza Ghavami; Gholamreza Fathpour; Zahra Amirghofran
Journal:  Pathol Oncol Res       Date:  2017-08-21       Impact factor: 3.201

4.  Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.

Authors:  Prajitha Mohandas Edathara; Manjula Gorre; Sailaja Kagita; Sugunakar Vuree; Anuradha Cingeetham; Santhoshi Rani Nanchari; Phanni Bhushann Meka; Sandhya Annamaneni; Raghunadha Rao Digumarthi; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2015-11-13

5.  CD95 rs1800682A/G variant and tumor risk in Asians: evidence from a meta-analysis of 36 case-control studies containing 22,438 samples.

Authors:  Cheng Jin; Xiaomin Wu; Yuanlong Gu; Fenglai Yuan; Qinghai Ye; Feng Dai; Lijie Zhu; Yuanyuan Mi
Journal:  Med Sci Monit       Date:  2015-02-27

6.  Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its regulatory genes in gastric cancer tissues.

Authors:  Jihan Wang; Zhaohui Ni; Zipeng Duan; Guoqing Wang; Fan Li
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

7.  Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.

Authors:  Ying Chen; Hanfei Wang; Yunwen Yan; Min Ren; Cunye Yan; Benzhong Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 8.  Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia.

Authors:  Narges Aberuyi; Soheila Rahgozar; Elaheh Sadat Ghodousi; Kamran Ghaedi
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

9.  An Investigation of the Growth Inhibitory Capacity of Several Medicinal Plants From Iran on Tumor Cell Lines.

Authors:  Maryam Esmaeilbeig; Seyed Amin Kouhpayeh; Zahra Amirghofran
Journal:  Iran J Cancer Prev       Date:  2015-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.